跳至主要内容
临床试验/NCT02935647
NCT02935647已完成1 期

Burst Suppression Anesthesia for Treatment of Severe Depression

University of Utah1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2016年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
11
试验地点
1
主要终点
Hamilton Rating Scale for Depression

研究概览

简要总结

This study is designed to determine if the antidepressant effects of deep anesthesia via propofol are related to EEG burst suppression.

详细描述

Ten individuals with treatment resistant major depressive disorder will undergo 10 treatments of deep anesthesia via propofol over a 3-week period. Depression will be evaluated before and after treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Diagnosis of Major Depressive Disorder (MDD) or bipolar Disorder (I or II, most recent episode must be depression
  • Failed at least 2 anti-depressant treatments and no ECT in past 6 months
  • Age between 18-55 years
  • BMI < 35
  • Hamilton Rating Scale for Depression (HSRD) score > 18
  • Quick Inventory of Depression Scale (QIDS) score > 10.

排除标准

  • • Diagnosis of primary psychotic disorder, dysthymia, or personality disorder
  • Significant pre-morbid cognitive impairment
  • Hypertension and current use of ACE inhibitor or AR blocker medications
  • Symptomatic coronary artery disease or congestive heart failure
  • History of transient ischemic or neurologic signs during the past year
  • History of or susceptibility to malignant hyperthermia
  • Contraindication to isoflurane or propofol anesthesia (as determined by anesthesiologist)
  • Diabetes requiring insulin
  • Poor kidney function
  • Chronic use of benzodiazepines or opioids
  • Individuals incompetent to provide consent (e.g. catatonic, psychotic).

研究组 & 干预措施

Propofol

Experimental

Participants will receive intravenous propofol titrated rapidly at 100-200 mcg/kg/min to reach 80% burst-suppression and then maintained there for 15 minutes, after which propofol administration will be discontinued and the participant will be allowed to awaken.

干预措施: Diprivan (Drug)

结局指标

主要结局

Hamilton Rating Scale for Depression

时间窗: 3 weeks

次要结局

  • Quick Inventory of Depressive Symptoms(3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian Mickey

Principal Investigator

University of Utah

研究点 (1)

Loading locations...

相似试验